Evaluation of the Incidence of New-Onset Atrial Fibrillation After Aortic Valve Replacement.

ABSTRACT:

Importance

Data on the burden of new-onset atrial fibrillation after transcatheter aortic valve implantation (TAVI) and surgical aortic valve replacement (AVR) is limited mostly to small series or post hoc analyses of clinical trials.

Objectives

To evaluate the incidence of new-onset atrial fibrillation and assess the incidence of in-hospital mortality associated with new-onset atrial fibrillation after TAVI and AVR.

Design, setting, and participants

In this population-based observational study using the National Inpatient Sample and a validation cohort from the New York state inpatient database, the National Inpatient Sample was queried from January 1, 2012, to September 30, 2015, and the New York state inpatient database was queried from January 1, 2012, to December

SUBMITTER: Kalra R 

PROVIDER: S-EPMC6547161 | biostudies-literature | 2019 Aug

REPOSITORIES: biostudies-literature